• No results found

Growth hormone-releasing factor

Pulsatile growth hormone secretion in normal man during a continuous 24 hour infusion of human growth hormone releasing factor (1 40)  Evidence for intermittent somatostatin secretion

Pulsatile growth hormone secretion in normal man during a continuous 24 hour infusion of human growth hormone releasing factor (1 40) Evidence for intermittent somatostatin secretion

... Growth hormone (GH) secretory patterns were studied in a patient with ectopic growth hormone releasing factor (GRF) secretion and in normal men given continuous infusions of ...

8

Exogenous growth hormone inhibits growth hormone releasing factor induced growth hormone secretion in normal men

Exogenous growth hormone inhibits growth hormone releasing factor induced growth hormone secretion in normal men

... human growth hormone-releasing factor (GRF), the possible existence of such a mechanism was reexplored by examining the effect of exogenous GH on the GH response induced by GRF-44-NH2 in six ...

6

Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man

Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man

... tumor growth hormone releasing factor [hpGRF(1-40)] was determined in normal adult male subjects by single injection and constant infusion ...

9

Effect of Growth Hormone-Releasing Factor on Growth Hormone Release in Children with Radiation-Induced Growth Hormone Deficiency

Effect of Growth Hormone-Releasing Factor on Growth Hormone Release in Children with Radiation-Induced Growth Hormone Deficiency

... Schriock EA, Lustig RH, Rosenthal SM, et al: Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and [r] ...

8

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor  Intermittent secretion or response attenuation

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor Intermittent secretion or response attenuation

... tumor growth hormone (GH) releasing factor (hpGRF[1- 40]) as a single injection to normal human subjects stimulates the secretion of GH in a dose- responsive ...

9

Thyroid hormone modulation of the hypothalamic growth hormone (GH) releasing factor pituitary GH axis in the rat

Thyroid hormone modulation of the hypothalamic growth hormone (GH) releasing factor pituitary GH axis in the rat

... insulin-like growth factor-1 levels in Tx ...thyroid hormone acts as an inhibitory modulator of GRF secretion, probably not involving a feedback mechanism through ...thyroid hormone on ...

9

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

... triggering factor of the syndrome ...endothelial growth factor (VEGF), as well as VEGF receptor 2 (VEGFR-2) messenger ribonucleic acid (mRNA), increases significantly, rising to a maximum that ...

5

Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature

Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature

... of growth hormone (GH) leading to hepatic overproduction of insulin-like growth factor-1 ...of growth hormone-releasing hormone (GHRH) and growth ...

6

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin like growth factor 1 resulting in elevated sustainable insulin like growth factor 1 and insulin like growth factor binding protein 3 plasma levels: a case report

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin like growth factor 1 resulting in elevated sustainable insulin like growth factor 1 and insulin like growth factor binding protein 3 plasma levels: a case report

... GH-releasing hormone (GHRH)/somatostatin (SS) con- centrations, GHRH/SS mRNA levels, and plasma GH and somatomedin-C (IGF-1) concentrations in rats made deficient by exposing dams with propylthiouracil in ...

5

Immunocytochemical evidence for growth hormone-releasing hormone in the tanycytes of the median eminence of the rat

Immunocytochemical evidence for growth hormone-releasing hormone in the tanycytes of the median eminence of the rat

... In order to determine the number of GHRH-im- munoreactive tanycytes (only tanycytes in which the cell nuclei was apparent were scored), we studied 25 sections of the median eminence in the cranio-cau- dal transitional ...

8

Regulatory mechanisms of growth hormone secretion are sexually dimorphic

Regulatory mechanisms of growth hormone secretion are sexually dimorphic

... dimorphic growth hormone (GH) secretory pattern is important in the determination of gender-specific patterns of growth and metabolism in ...insulin-like growth factor I ...and ...

13

Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways

Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways

... Finally, when we expanded our in vitro findings by topically applying the GHRH agonist, MR-409, to wounded animals, the wounds of MR agonist-treated animals healed more rapidly than the controls in a dosage- dependent ...

12

Growth hormone releasing peptides: Physiological studies in man

Growth hormone releasing peptides: Physiological studies in man

... plus GHRH have been postulated to occur via a hypothalamic anatomic site of action, though the exact mechanism by which this happens remains unclear. GHRPs do not inhibit hypothalamic SS release but can induce GHRH ...

259

Clinical effectiveness and cost effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation

Clinical effectiveness and cost effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation

... of growth hormone (GH) ...of growth hormone releasing hormone (GHRH) or to extra-pituitary tumours that secrete GH or ...insulin-like growth factor-1 (IGF-1) secre- ...

16

Endogenous growth hormone (GH) releasing hormone is required for GH responses to pharmacological stimuli

Endogenous growth hormone (GH) releasing hormone is required for GH responses to pharmacological stimuli

... GH releasing factor that might be able to exert its full effect only in the presence of activated GHRH ...“third factor” in the regula- tion of GH secretion. A GH-releasing peptide-like ...

8

Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss

Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss

... This boy (II:2, Fig. 1a) was a product of an uneventful pregnancy and normal vaginal delivery at 39 weeks of gestation, whose healthy consanguineous parents had previously lost a daughter in infancy probably because of ...

10

A Case of Ectopic Growth Hormone Releasing  Hormone (GHRH) from Pancreatic  Neuroendocrine Tumor Resistant to Therapy

A Case of Ectopic Growth Hormone Releasing Hormone (GHRH) from Pancreatic Neuroendocrine Tumor Resistant to Therapy

... A Case of Ectopic Growth Hormone Releasing Hormone GHRH from Pancreatic Neuroendocrine Tumor Resistant to Therapy Ohoud Almohareb1*, Juan Rivera2.. Specialized Diabetes and Endocrine Cen[r] ...

5

A Review of Endocrine Disorders in Thalassaemia

A Review of Endocrine Disorders in Thalassaemia

... levels. It usually occurs in severely anaemic and/or iron overload thalassaemics but is uncommon in optimally treated patients [7,65]. The pathogenesis is again unclear but thought to relate to lipid perioxdiation, free ...

10

Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double blind, controlled clinical trial

Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double blind, controlled clinical trial

... Adrenocorticotrophic hormone-releasing factor; DLMO: Dim light melatonin onset; DRLT: Dim red light therapy; DSM: Diagnostic and Statistical Manual of mental disorders; EPDS: Edinburgh Postnatal ...

13

Pituitary Hypoplasia in Patients with a Mutation in the Growth hormone–releasing Hormone Receptor Gene

Pituitary Hypoplasia in Patients with a Mutation in the Growth hormone–releasing Hormone Receptor Gene

... Ours is one of the first studies in which a molec- ular basis for pituitary hypoplasia in humans has been shown. Most cases of congenital growth hor- mone deficiency are idiopathic, although many po- tential ...

5

Show all 10000 documents...

Related subjects